Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in ...

Another of the psychiatry drugs Neurocrine Biosciences licensed from Takeda has stumbled in the clinic. | Another of the ...

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

The surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric ...

Frontiers in Psychiatry is proud to launch this year's Women in Psychiatry: Psychopharmacology collection to showcasing ...